Serum C-peptide level and the risk of cardiovascular diseases mortality and all-cause mortality: a meta-analysis and systematic review
Open Access
- 7 July 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1205481
Abstract
Aims and background: Recently, the serum of C-peptide has been the focus of researchers as a possible predictor of mortality. However, the possible association of serum C-peptide with cardiovascular diseases (CVDs) mortality and all-cause mortality has not been clearly identified. This meta-analysis aimed to assess the relationship between serum C-peptide and the risk of CVDs mortality and all-cause mortality.Methods: A comprehensive and systematic search was performed in various important databases, including the PubMed, Web of Science, and Scopus to find relevant studies up to November 2022. The reported hazard ratio (HR) [95% confidence interval (CI)] for all studies was converted into log HR, and their SD was calculated. Then to compute the pooled HR, the random-effects model with inverse variance weighting method was performed.Results: Twenty-three studies were included in the meta-analysis. Fourteen studies reported HR for all-cause mortality, and nine studies for CVDs-related mortality. The pooled results indicate a significant association between serum C-peptide and the risk of all-cause mortality (HR: 1.22; 95% CI: 1.12–1.32, I2 = 76.8%; P-value < 0.001). Also, higher serum C-peptide was related to the increased risk of CVDs mortality (HR: 1.38; 95% CI: 1.08–1.77, I2 = 81.8%; P-value = 0.012).Conclusions: Our investigation suggested that an increased level of serum C-peptide is associated with a higher risk of both CVDs and all-cause mortality. Further, large-scale studies and sufficient samples are recommended to present a convincing link between C-peptide and the risk of CVDs and all-cause mortality.Systematic Review Registration: identifier, CRD42022364842.Keywords
This publication has 48 references indexed in Scilit:
- Serum C-peptide levels and risk of death among adults without diabetes mellitusCanadian Medical Association Journal, 2013
- Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic AdultsJournal of the American Heart Association, 2012
- Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosaBMC Cancer, 2012
- A dietary pattern that is associated with C-peptide and risk of colorectal cancer in womenCancer Causes & Control, 2012
- Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle StudyJournal of Clinical Oncology, 2011
- Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancerBritish Journal of Cancer, 2010
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Diabetologia, 2010
- Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal CancerJournal of Clinical Oncology, 2009
- C‐Peptide and Atherogenesis: C‐Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus?Journal of Diabetes Research, 2008
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002